Molecular cancer biomarkers are any measurable molecular indicator of risk of cancer,
occurrence of cancer, or patient outcome. They may include germline or somatic genetic …

Background Detecting cancer at an early stage before clinical manifestation could be an
effective strategy to decrease cancer mortality. Thus, identifying liquid biopsy biomarkers …

Almost all clinical oncologists agree that the discovery of reliable, accessible, and non-
invasive biomarkers is necessary to decrease cancer mortality. It is possible to employ …

Cancer is a cause of high deaths worldwide and also a huge burden for the health system.
Cancer cells have unique properties such as a high rate of proliferation, self-renewal …

Mesenchymal stem cells (MSCs), one of the most common types of stem cells, are involved
in the modulation of the tumor microenvironment (TME). With the advancement of …

Lung cancer demands innovative approaches for early detection and targeted treatment. In
addressing this urgent need, exosomes play a pivotal role in revolutionizing both the early …

Background Exosomal miRNA had been proved as the promising biomarkers for multiple
cancers including epithelial ovarian cancer (EOC). This study aimed to validate the …

Simple Summary Exosomes are an emerging source of cancer biomarkers. Molecular
components of serum-derived exosomes have been addressed in several reports in the …

MicroRNA are non-coding small RNAs that bind to their target mRNA and cause mRNA
degradation or translation inhibition. MiRNA dysregulation is linked to a variety of human …

Non-small cell lung cancer (NSCLC) comprises 85% of all lung cancers and is a malignant
condition resistant to advanced-stage treatment. Despite the advancement in detection and …